GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
87 hedge funds and large institutions have $650M invested in GW Pharmaceuticals Plc American Depositary Shares in 2014 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 21 increasing their positions, 26 reducing their positions, and 26 closing their positions.
0% more funds holding
Funds holding: 87 → 87 (0)
0% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 26
19% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 26
25% less call options, than puts
Call options by funds: $35.4M | Put options by funds: $47M
26% less capital invested
Capital invested by funds: $884M → $650M (-$234M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$19.6M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$17M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$16.5M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$16.4M |
| 5 |
CCM
Cupps Capital Management
Chicago,
Illinois
|
+$8.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$21.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.6M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$18.9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$15.6M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$9.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Stifel Financial
St. Louis,
Missouri
| – | -$285K | -2,655 | Closed |
|
|
SCM
102
Sterling Capital Management
Charlotte,
North Carolina
| – | -$255K | -2,381 | Closed |
|
|
NPC
103
National Planning Corporation
El Segundo,
California
| – | -$234K | -2,180 | Closed |
|
|
HCM
104
Harvey Capital Management
Palm Beach,
Florida
| – | -$214K | -2,000 | Closed |
|
|
LCM
105
Landscape Capital Management
Englewood,
New Jersey
| – | -$204K | -1,900 | Closed |
|
|
SEC
106
Seven Eight Capital
New York
| – | -$172K | -1,600 | Closed |
|
|
FNBT
107
FineMark National Bank & Trust
Fort Myers,
Florida
| – | -$30K | -275 | Closed |
|
108
M&T Bank
Buffalo,
New York
| – | -$16K | -150 | Closed |
|
|
SGC
109
South Georgia Capital
Naperville,
Illinois
| – | -$11K | -100 | Closed |
|
|
RFA
110
Reilly Financial Advisors
La Mesa,
California
| – | -$5K | -50 | Closed |
|
|
TCM
111
Tradewinds Capital Management
Bellingham,
Washington
| – | -$3K | -25 | Closed |
|
|
PFG
112
Piershale Financial Group
Barrington,
Illinois
| – | -$2K | -18 | Closed |
|
GWPH Hedge Fund Activity: Q3 2014 in Review
87 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q3 2014, worth a combined $650M — down 26% from $884M a quarter earlier.
Fund positioning in GWPH was balanced in Q3 2014: 26 funds opened new positions, 26 closed out, 21 added to existing stakes and 26 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $19.6M. The largest seller was Jennison Associates, exiting entirely with an estimated $21.4M sold.
- 87 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $650M of GW Pharmaceuticals Plc American Depositary Shares stock for Q3 2014, down 26% quarter-over-quarter.
- 26 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q3 2014 and 26 closed out, a net change of 0 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q3 2014 was OrbiMed, an estimated $19.6M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q3 2014 was Jennison Associates, an estimated $21.4M sold.
Based on aggregated 13F filings for Q3 2014.